TickerStat.comwe like data

Evofem Biosciences, Inc. (EVFM)

Price$0.0077Cached quote
EVFMOTC
Loading local price history

Financial charts

Revenue

Net income

Total cash / debt

CashTotal debt

Financial statements

13 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013
Revenue$20.2M$19.4M$18.2M$16.8M$8.2M$446,000$0——————
Gross profit$15.6M$15.5M$11.7M$12.4M$4.2M−$22,000$0——————
Gross margin77.12%80.20%64.26%73.78%50.81%−4.93%———————
Research & development−$3.4M$1.8M$2.9M$25.0M$33.1M$17.1M$22.2M$43.4M$23.5M$6.6M$34.4M$5.2M$11.4M
Operating expenses$16.8M$27.0M$36.1M$101.0M$175.0M$104.1M$52.7M$77.6M$35.7M$12.0M$42.0M$9.6M$14.4M
Operating income$3.4M−$7.7M−$17.8M−$84.1M−$166.8M−$103.6M−$52.7M−$77.6M−$35.7M−$12.0M−$42.0M−$9.6M−$14.4M
Operating margin16.71%−39.64%−97.96%−499.64%−2,023.30%−23,234.08%———————
EBITDA$3.9M−$7.0M−$17.4M−$83.1M−$165.8M−$103.3M−$52.5M−$77.4M−$35.4M−$12.0M−$42.0M−$9.6M−$14.4M
EBITDA margin19.27%−36.29%−95.35%−493.61%−2,010.89%−23,166.37%———————
Net income$391,000−$8.9M$53.0M−$76.7M−$205.2M−$142.3M−$80.0M−$125.7M−$105.3M−$13.0M−$43.2M−$10.8M−$15.0M
Net profit margin1.94%−45.76%290.81%−455.53%−2,488.99%−31,907.85%———————
Basic EPSper basic share$0.00-$0.11$10.36-$167.42-$23.63-$31.80-$29.85-$86.10-$836.70-$84.90-$283.65-$482.40-$2,639.70
Diluted EPSper diluted share$0.00-$0.11$0.05-$167.42-$23.63-$31.80-$29.85-$86.10-$836.70-$84.90-$283.65-$482.40-$2,639.70
Review official source filings ↗

Owners

Reported shareholders

Ownership data is not available for this listing yet.

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about EVFM yet. Start the conversation.

Write the first post